Pioglitazone

InformationSF2523 is a highly selective and potent inhibitor ofPI3Kwith IC50 values of 34 nM, 158 nM, 9 nM, 241 nM and 280 nM forPI3Kα, PI3Kγ, DNA-PK, BRD4 and mTOR, respectively.TargetsDNA-PK (Cell-free assay): PI3Kα (Cell-free assay): PI3Kγ

InformationSF2523 is a highly selective and potent inhibitor ofPI3Kwith IC50 values of 34 nM, 158 nM, 9 nM, 241 nM and 280 nM forPI3Kα, PI3Kγ, DNA-PK, BRD4 and mTOR, respectively.TargetsDNA-PK (Cell-free assay): PI3Kα (Cell-free assay): PI3Kγ

The SFTPC antibody from Proteintech is a Rabbit Polyclonal antibody to a Recombinant Protein of human SFTPC. This antibody recognizes Human, Rat antigen.

InformationSMI-16a is a selectivePimkinase inhibitor with IC50 values of 150 nM and 20 nM for Pim1 and Pim2 respectively.TargetsPim2 : Pim1 20 nM: 150 nM.

InformationSMI-16a is a selectivePimkinase inhibitor with IC50 values of 150 nM and 20 nM for Pim1 and Pim2 respectively.TargetsPim2 : Pim1 20 nM: 150 nM.

InformationSMI-16a is a selectivePimkinase inhibitor with IC50 values of 150 nM and 20 nM for Pim1 and Pim2 respectively.TargetsPim2 : Pim1 20 nM: 150 nM.

A cell-permeable, nonpetidic nicotinoyl hydrazone that selectively suppresses STAT5 by targeting its SH2 domain (IC₅₀ = 47 &microM against STAT5&beta SH2 domain EPO peptide binding activity).

Tricetin is a potent competitive inhibitor of the Keap1-Nrf2 Protein Protein Interaction (PPI). Tricetin protects against 6-OHDA-induced neurotoxicity in Parkinson's disease model by activating Nrf2/HO-1 signaling pathway and preventing

Application Prostate cancer (PCA) is the most frequently diagnosed cancer among men in the USA, with over 150 000 new cases expected annually. Approximately 6% become metastatic, with a 5-yr survival rate of only 29%.